Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Over 60 per cent of the fixed-dose combination (FDC) drugs used for treating mental health disorders in India are 'unapproved' and lack proven therapeutic value, the study found
CDSCO aims to phase out these combinations and codeine-based drugs in a phased manner
If this goes through, drugmakers will have the liberty to raise the prices of these drugs by up to 10 per cent every year
Of the 1,600 FDC drugs that are under watch now, around 600 are learnt to be vitamins
I fully agree with the points raised in "Knee-jerk reaction" (March 18). It is a well-known fact that combination drugs have been in the market for quite some time now, and that people have been using them extensively and benefitting from them greatly, too. How come the government woke up now on the issue, when these medicines have proven to be effective in their fields? Has any test been carried out to prove that these are harmful? If yes, why were such tests not done before permission was given to companies to manufacture the drugs in question?While I appreciate the government's eagerness to protect the common man from the ill-effects of extensive use of non-prescription medicines (over-the-counter drugs), I wonder why there is no regulation in place to check the veracity of the claims made by the manufacturers before they carry out commercial production. In my opinion, all over-the-counter medicines should be banned and all pharmaceutical products should be sold only on prescription